We now have two FDA-approved disease-modifying treatments for Alzheimer's disease, and hundreds of clinical trials are ...

The next Alzheimer’s treatment could come from an unexpected place. In new research released this week, scientists have found ...

New drug approvals and a federal dementia care pilot program among the year's significant developments, according to the ...

The two biggest advances in treatment have been the introduction ... Neurologist Dr Richard Harvey, medical director of the Alzheimer's Society, says: 'The original work on these drugs was aimed ...

Yet despite decades of research, no treatment has been created that arrests Alzheimer’s cognitive deterioration, let alone ...

Light therapy is emerging as a promising, non-pharmacological treatment for Alzheimer’s disease, offering significant improvements in sleep and psycho-behavioral symptoms such as depression and ...

The blood–brain barrier is a highly selective shield that protects the brain from harmful substances in the bloodstream.

Advances in scientific research and diagnostic tools are transforming how we think about and treat Alzheimer’s disease.

Dopamine’s involvement in Alzheimer’s treatment stems from its ability ... and delivery methods for dopamine-enhancing medications. Advances in technology, such as imaging tools to monitor ...

LATE is a prevalent condition in late life and can contribute to memory loss and cognitive decline, according to report co-author Rebecca M. Edelmayer, Ph.D., Alzheimer’s Association vice president of ...

With an estimated 6.9 million Americans aged 65 and older currently living with Alzheimer’s disease, the road to a cure seems ...

LATE-NC diagnostic criteria improve differentiation from Alzheimer's, addressing challenges in memory-loss syndromes and ...